DEC 12, 2018 4:26 PM PST

Switch HIV Infection

WRITTEN BY: Nicholas Breehl

The human immunodeficiency virus continues to be a threat to a large population of people today. No effective cure exists for HIV. Even with preventative treatment and medical care after infection, the transfer and persistence of the virus can endure. Latent HIV infection remains elusive to the immune system allowing for it to thrive undetected in the body.

In a recently shared study in the journal Proceedings of the National Academy of Sciences, performed by researchers at the University of Illinois at Chicago, data suggest that a genetic switch that causes latent HIV infected cells to begin to replicate can be manipulated to eradicate the virus from the body completely. Over time, HIV can destroy so many of these cells that the body can’t fight off infections and disease. These specialized cells help the immune system fight off infections. Untreated, HIV reduces the number of CD4 cells (T cells) in the body.

The researchers share that, “the reservoir of HIV latently infected cells is the major obstacle for complete eradication of HIV infection. Latency and its transactivation in HIV-infected cells are controlled by the intracellular HIV Tat gene circuit.”

"We need to understand better the mechanisms that regulate HIV latency, so we can identify new opportunities for intervention and develop better drugs that can either lock viral particles in a latent state, or kill latent cells, or both," shared Liang, Professor of Bioengineering.

The scientists display that a genetic switch can be utilized as a cure for HIV infection. When HIV infects the genome of a cell, the Tat gene circuit controls the transcription of the viral DNA. As the Tat gene activates HIV, the cell becomes overburden with the virus and explodes, effectively permitting the infection of neighboring cells. The Tat gene is switched off during latent HIV infection.

"By targeting the Tat gene circuit with drugs or small molecules to activate it, we would be able to cause latently-infected cells to start producing more virus, and then they can be destroyed by the immune system," said Jie Liang, the Richard and Loan Hill Professor of Bioengineering in the University of Illinois at Chicago College of Engineering and a lead author of the paper. To date the drugs that aim for the tat gene to make these purposed changes.

The team finds that the Tat gene’s activation and inactivation is a spontaneous event and that its reactivation is rare. By making use of algorithms and models, their team was able to accurately map the probability of different reactions that cause Tat activation. The results of their studies provide new ways of targeting latent cells that may lead to the eradication of the HIV.

"Our results suggest that by controlling HIV latency through manipulation of the Tat gene circuit, effective therapeutic strategies can be identified that would one day provide a cure for HIV," Liang said.

Sources: PNAS, Science Daily, CDCYouTube

About the Author
You May Also Like
APR 20, 2020
Cell & Molecular Biology
Worst COVID-19 Cases May be Caused by Immune Cell Overactivity
APR 20, 2020
Worst COVID-19 Cases May be Caused by Immune Cell Overactivity
The SARS-CoV-2 virus causea huge range of symptoms, and researchers are learning more about the worst cases, which may h ...
APR 21, 2020
Drug Discovery & Development
Researchers Develop COVID-19 Nasal Spray Vaccine
APR 21, 2020
Researchers Develop COVID-19 Nasal Spray Vaccine
Researchers from the University of Waterloo in Canada are working on a DNA-based vaccine for COVID-19 that can be applie ...
MAY 17, 2020
Coronavirus
Substantial Antiviral Response Seen in Adults Recovered from COVID-19
MAY 17, 2020
Substantial Antiviral Response Seen in Adults Recovered from COVID-19
Some good news comes as researchers scramble for potential vaccine candidates amidst the global COVID-19 pandemic. Scien ...
JUN 09, 2020
Immunology
Peacekeeping Engineered T Cells Restore the Balance in Diabetes
JUN 09, 2020
Peacekeeping Engineered T Cells Restore the Balance in Diabetes
For patients with type 1 diabetes, hope is around the corner with a new experimental therapy that uses genetically modif ...
JUL 08, 2020
Health & Medicine
The Myths About CBD and Coronavirus
JUL 08, 2020
The Myths About CBD and Coronavirus
Research collected over the last 20 years suggests that cannabidiol – the primary cannabinoid in CBD oil – h ...
AUG 05, 2020
Coronavirus
Age-old Immune Components Affecting COVID-19 Severity
AUG 05, 2020
Age-old Immune Components Affecting COVID-19 Severity
One of the most unsettling aspects of the coronavirus pandemic is the wide range of severity those affected seem to expe ...
Loading Comments...